BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol. 2002;39:183-193. [PMID: 11788206 DOI: 10.1016/s0735-1097(01)01742-9] [Cited by in Crossref: 268] [Cited by in F6Publishing: 48] [Article Influence: 13.4] [Reference Citation Analysis]
Number Citing Articles
1 Ma J, Zhao N, Zhu D. Bioabsorbable zinc ion induced biphasic cellular responses in vascular smooth muscle cells. Sci Rep 2016;6:26661. [PMID: 27248371 DOI: 10.1038/srep26661] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 7.7] [Reference Citation Analysis]
2 Wong W, Lai CN, Cheng W, Tung L, Chang RC, Leung FK. Polymer–Metal Composite Healthcare Materials: From Nano to Device Scale. J Compos Sci 2022;6:218. [DOI: 10.3390/jcs6080218] [Reference Citation Analysis]
3 Golino L, Caiazzo G, Calabrò P, Colombo A, Contarini M, Fedele F, Gabrielli G, Galassi AR, Golino P, Scotto di Uccio F, Tarantini G, Argentino V, Balbi M, Bernardi G, Boccalatte M, Bonmassari R, Bottiglieri G, Caramanno G, Cesaro F, Cigala E, Chizzola G, Di Lorenzo E, Intorcia A, Fattore L, Galli S, Gerosa G, Giannotta D, Grossi P, Monda V, Mucaj A, Napodano M, Nicosia A, Perrotta R, Pieri D, Prati F, Ramazzotti V, Romeo F, Rubino A, Russolillo E, Spedicato L, Tuccillo B, Tumscitz C, Vigna C, Bertinato L, Armigliato P, Ambrosini V. Excimer laser technology in percutaneous coronary interventions: Cardiovascular laser society's position paper. Int J Cardiol 2022:S0167-5273(21)02057-X. [PMID: 34995700 DOI: 10.1016/j.ijcard.2021.12.054] [Reference Citation Analysis]
4 Remkes WS, Badings EA, Hermanides RS, Rasoul S, Dambrink JE, Koopmans PC, The SH, Ottervanger JP, Gosselink AT, Hoorntje JC, Suryapranata H, van 't Hof AW. Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction. Open Heart 2016;3:e000455. [PMID: 27933192 DOI: 10.1136/openhrt-2016-000455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Yoon KW, Kim YJ. In-stent stenosis of stent assisted endovascular treatment on intracranial complex aneurysms. J Korean Neurosurg Soc 2010;48:485-9. [PMID: 21430973 DOI: 10.3340/jkns.2010.48.6.485] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
6 Wang JN, Shi N, Chen SY. Manganese superoxide dismutase inhibits neointima formation through attenuation of migration and proliferation of vascular smooth muscle cells. Free Radic Biol Med 2012;52:173-81. [PMID: 22062629 DOI: 10.1016/j.freeradbiomed.2011.10.442] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
7 Kasza G, Kollár L, Rőth E, Vincze A, Gömöri E. Histological examination of vascular lesions caused by stent implantation in humans and in comparative experimental animal model. Acta Biol Hung 2012;63:1-14. [PMID: 22453796 DOI: 10.1556/ABiol.63.2012.1.1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Rodriguez-Menocal L, Wei Y, Pham SM, St-Pierre M, Li S, Webster K, Goldschmidt-Clermont P, Vazquez-Padron RI. A novel mouse model of in-stent restenosis. Atherosclerosis 2010;209:359-66. [PMID: 19875114 DOI: 10.1016/j.atherosclerosis.2009.09.071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
9 Vilahur G, Padro T, Badimon L. Atherosclerosis and thrombosis: insights from large animal models. J Biomed Biotechnol 2011;2011:907575. [PMID: 21274431 DOI: 10.1155/2011/907575] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
10 Hui DY. Intimal hyperplasia in murine models. Curr Drug Targets 2008;9:251-60. [PMID: 18336244 DOI: 10.2174/138945008783755601] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 4.2] [Reference Citation Analysis]
11 Chen YF, Wu KJ, Wood WG. Paeonia lactiflora Extract Attenuating Cerebral Ischemia and Arterial Intimal Hyperplasia Is Mediated by Paeoniflorin via Modulation of VSMC Migration and Ras/MEK/ERK Signaling Pathway. Evid Based Complement Alternat Med 2013;2013:482428. [PMID: 23818926 DOI: 10.1155/2013/482428] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
12 Fishbein I, Alferiev IS, Nyanguile O, Gaster R, Vohs JM, Wong GS, Felderman H, Chen IW, Choi H, Wilensky RL, Levy RJ. Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents. Proc Natl Acad Sci U S A 2006;103:159-64. [PMID: 16371477 DOI: 10.1073/pnas.0502945102] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 3.9] [Reference Citation Analysis]
13 Jimenez-Valero S, Moreno R, Sanchez-Recalde A, Galeote G, Calvo L, Viana A, Lopez de Sá E, López-Sendón J. Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era? Ther Adv Cardiovasc Dis 2008;2:137-46. [PMID: 19124417 DOI: 10.1177/1753944708090573] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
14 Barlis P, Horrigan MC, Chan RK, Ajani AE, Proimos G, Schumer W, van Gaal WJ, Rowe M, Eccleston D, Yan BB, Mun Cheong Y, Oliver LE, Clark DJ. What is the best contemporary treatment for in-stent restenosis? Cardiovasc Revasc Med 2005;6:179-81. [PMID: 16326381 DOI: 10.1016/j.carrev.2005.10.001] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
15 Granada JF, Kaluza GL, Raizner A. Drug-eluting stents for cardiovascular disorders. Curr Atheroscler Rep 2003;5:308-16. [PMID: 12793972 DOI: 10.1007/s11883-003-0054-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
16 Puranik AS, Dawson ER, Peppas NA. Recent advances in drug eluting stents. Int J Pharm 2013;441:665-79. [PMID: 23117022 DOI: 10.1016/j.ijpharm.2012.10.029] [Cited by in Crossref: 107] [Cited by in F6Publishing: 83] [Article Influence: 10.7] [Reference Citation Analysis]
17 Berenguer A, Mainar V, Bordes P, Valencia J, Gómez S, Lozano T. Incidence and predictors of restenosis after sirolimus-eluting stent implantation in high-risk patients. Am Heart J 2005;150:536-42. [PMID: 16169337 DOI: 10.1016/j.ahj.2004.10.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
18 Varela N, Lanas F, Salazar LA, Zambrano T. The Current State of MicroRNAs as Restenosis Biomarkers. Front Genet 2019;10:1247. [PMID: 31998354 DOI: 10.3389/fgene.2019.01247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
19 Arjomand H, Turi ZG, Mccormick D, Goldberg S. Percutaneous coronary intervention: historical perspectives, current status, and future directions. American Heart Journal 2003;146:787-96. [DOI: 10.1016/s0002-8703(03)00153-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Eeckhout E, Berger A, Roguelov C, Lyon X, Imsand C, Fivaz-Arbane M, Girod G, De Benedetti E. Direct stenting with a combined intravascular ultrasound-coronary stent delivery platform: a feasibility trial. Catheter Cardiovasc Interv 2003;59:451-4. [PMID: 12891604 DOI: 10.1002/ccd.10578] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
21 Burke SE, Kuntz RE, Schwartz LB. Zotarolimus (ABT-578) eluting stents. Adv Drug Deliv Rev 2006;58:437-46. [PMID: 16581153 DOI: 10.1016/j.addr.2006.01.021] [Cited by in Crossref: 69] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
22 Fonseca KR, Trindade BM, Campos TP. Development of a voxel model of the heart for dosimetry. Artif Organs 2011;35:459-64. [PMID: 21595712 DOI: 10.1111/j.1525-1594.2011.01258.x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
23 Yang Z, Zhao X, Hao R, Tu Q, Tian X, Xiao Y, Xiong K, Wang M, Feng Y, Huang N, Pan G. Bioclickable and mussel adhesive peptide mimics for engineering vascular stent surfaces. Proc Natl Acad Sci U S A 2020;117:16127-37. [PMID: 32601214 DOI: 10.1073/pnas.2003732117] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 13.5] [Reference Citation Analysis]
24 Iijima R, Ikari Y, Tsunoda T, Nakamura M, Hara K, Yamaguchi T. Impact of intima re-intrusion and expansion within 100 minutes on late lumen loss in percutaneous coronary intervention for diffuse in-stent restenosis. Heart 2004;90:1071-2. [PMID: 15310711 DOI: 10.1136/hrt.2003.024042] [Reference Citation Analysis]
25 Shuvalova YA, Kaminnyi AI, Meshkov AN, Shirokov RO, Samko AN. Association between polymorphisms of eNOS and GPx-1 genes, activity of free-radical processes and in-stent restenosis. Mol Cell Biochem. 2012;370:241-249. [PMID: 22890915 DOI: 10.1007/s11010-012-1419-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
26 Liang KW, Ting CT, Yin SC, Chen YT, Lin SJ, Liao JK, Hsu SL. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. Biochem Pharmacol 2006;71:806-17. [PMID: 16448624 DOI: 10.1016/j.bcp.2005.12.028] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
27 Du JB, Zhang W, Li N, Jiang H, Liu Y, Gao J, Chen ST, Cong HL, Wei YL. Association study of matrix metalloproteinase 3 5A/6A polymorphism with in-stent restenosis after percutaneous coronary interventions in a Han Chinese population. J Int Med Res 2020;48:300060519827145. [PMID: 30732526 DOI: 10.1177/0300060519827145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Chen X, Assadsangabi B, Hsiang Y, Takahata K. Enabling Angioplasty-Ready "Smart" Stents to Detect In-Stent Restenosis and Occlusion. Adv Sci (Weinh) 2018;5:1700560. [PMID: 29876203 DOI: 10.1002/advs.201700560] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
29 Cole JH, Weintraub WS. Restenosis: are the implications changing? Am Heart J 2004;147:197-9. [PMID: 14760312 DOI: 10.1016/j.ahj.2003.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
30 Du Q, Qian MM, Liu PL, Zhang L, Wang Y, Liu DH. Glycation of high-density lipoprotein triggers oxidative stress and promotes the proliferation and migration of vascular smooth muscle cells. J Geriatr Cardiol 2017;14:473-80. [PMID: 28868076 DOI: 10.11909/j.issn.1671-5411.2017.07.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Descovich X, Pontrelli G, Melchionna S, Succi S, Wassertheurer S. MODELING FLUID FLOWS IN DISTENSIBLE TUBES FOR APPLICATIONS IN HEMODYNAMICS. Int J Mod Phys C 2013;24:1350030. [DOI: 10.1142/s0129183113500307] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
32 Zhao S, Zhong Z, Qi G, Shi L, Tian W. Effects of Cilostazol-Based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation: An Updated Meta-Analysis of the Randomized Controlled Trials. Clin Drug Investig 2019;39:1-13. [PMID: 30251232 DOI: 10.1007/s40261-018-0711-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Saia F, Lemos PA, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Sianos G, Smits PC, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW. Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Heart 2004;90:1183-8. [PMID: 15367519 DOI: 10.1136/hrt.2003.025536] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
34 Song T, Fu Y, Wang Y, Li W, Zhao J, Wang X, Wang H, Zhao Y, Fu X. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI. BMC Cardiovasc Disord 2021;21:24. [PMID: 33413149 DOI: 10.1186/s12872-020-01839-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Elhendy A, Tsutsui JM, O'Leary EL, Xie F, Majeed F, Porter TR. Evaluation of restenosis and extent of coronary artery disease in patients with previous percutaneous coronary interventions by dobutamine stress real-time myocardial contrast perfusion imaging. Heart 2006;92:1480-3. [PMID: 16606862 DOI: 10.1136/hrt.2005.086140] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
36 Zheng GH, Liu JP, Wang NS, Chen HY, Chu JF. Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention. Evid Based Complement Alternat Med 2012;2012:253409. [PMID: 22454659 DOI: 10.1155/2012/253409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
37 Kapur A, Malik IS. Is surgery still the preferred option for coronary revascularisation in diabetics with multivessel coronary disease? Heart 2002;87:407-9. [PMID: 11997403 DOI: 10.1136/heart.87.5.407] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Zhang QZ, Guo YD, Li HM, Wang RZ, Guo SG, Du YF. Protection against cerebral infarction by Withaferin A involves inhibition of neuronal apoptosis, activation of PI3K/Akt signaling pathway, and reduced intimal hyperplasia via inhibition of VSMC migration and matrix metalloproteinases. Adv Med Sci 2017;62:186-92. [PMID: 28282606 DOI: 10.1016/j.advms.2016.09.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
39 Kim SM, Park KS, Lih E, Hong YJ, Kang JH, Kim IH, Jeong MH, Joung YK, Han DK. Fabrication and characteristics of dual functionalized vascular stent by spatio-temporal coating. Acta Biomater 2016;38:143-52. [PMID: 27109766 DOI: 10.1016/j.actbio.2016.04.029] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
40 Liu CH, Chen SC, Hsiao HM. A Single-Connector Stent Antenna for Intravascular Monitoring Applications. Sensors (Basel) 2019;19:E4616. [PMID: 31652844 DOI: 10.3390/s19214616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Marino BC, Nascimento GA, Rabelo W, Marino MA, Marino RL, Ribeiro AL. Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes. Arq Bras Cardiol 2015;104:375-86. [PMID: 25651344 DOI: 10.5935/abc.20140216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
42 Liu SJ, Yin CX, Ding MC, Xia SY, Shen QM, Wu JD. Berberine suppresses in vitro migration of human aortic smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF-κB. BMB Rep 2014;47:388-92. [PMID: 24286329 DOI: 10.5483/bmbrep.2014.47.7.186] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
43 Weaver JD, Ku DN. A Study on the Effects of Covered Stents on Tissue Prolapse. Journal of Biomechanical Engineering 2012;134:024505. [DOI: 10.1115/1.4006199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Masson R, Manthripragada G, Liu R, Tavakoli J, Mok K. Possible Precipitation of Acute Coronary Syndrome with Immune Checkpoint Blockade: A Case Report. Perm J 2020;24:1. [PMID: 33482971 DOI: 10.7812/TPP/20.037] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Rawlins J, Din JN, Talwar S, O'Kane P. Coronary Intervention with the Excimer Laser: Review of the Technology and Outcome Data. Interv Cardiol 2016;11:27-32. [PMID: 29588701 DOI: 10.15420/icr.2016:2:2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
46 Mekki M, Durual S, Scherrer SS, Lammers J, Wiskott HWA. Optimization of Plasma Treatment, Manipulative Variables and Coating Composition for the Controlled Filling and Coating of a Microstructured Reservoir Stent. Journal of Medical Devices 2009;3:011005. [DOI: 10.1115/1.3081394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
47 Mehdizadeh A, Ali MSM, Takahata K, Al-sarawi S, Abbott D. A recoil resilient lumen support, design, fabrication and mechanical evaluation. J Micromech Microeng 2013;23:065001. [DOI: 10.1088/0960-1317/23/6/065001] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
48 Tahir H, Bona-Casas C, Hoekstra AG. Modelling the effect of a functional endothelium on the development of in-stent restenosis. PLoS One 2013;8:e66138. [PMID: 23785479 DOI: 10.1371/journal.pone.0066138] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
49 Shoukry A, El-sherbieny I, Swelam E. Association of insulin resistance, insulin and leptin levels with coronary in-stent restenosis. The Egyptian Heart Journal 2012;64:35-42. [DOI: 10.1016/j.ehj.2011.08.005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Tahir H, Hoekstra AG, Lorenz E, Lawford PV, Hose DR, Gunn J, Evans DJ. Multi-scale simulations of the dynamics of in-stent restenosis: impact of stent deployment and design. Interface Focus 2011;1:365-73. [PMID: 22670206 DOI: 10.1098/rsfs.2010.0024] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
51 Alghrairi M, Sulaiman N, Mutashar S. Health Care Monitoring and Treatment for Coronary Artery Diseases: Challenges and Issues. Sensors (Basel) 2020;20:E4303. [PMID: 32752231 DOI: 10.3390/s20154303] [Reference Citation Analysis]
52 Scott NA. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury. Adv Drug Deliv Rev 2006;58:358-76. [PMID: 16733073 DOI: 10.1016/j.addr.2006.01.015] [Cited by in Crossref: 116] [Cited by in F6Publishing: 105] [Article Influence: 7.3] [Reference Citation Analysis]
53 Purnama A, Hermawan H, Champetier S, Mantovani D, Couet J. Gene expression profile of mouse fibroblasts exposed to a biodegradable iron alloy for stents. Acta Biomater 2013;9:8746-53. [PMID: 23499988 DOI: 10.1016/j.actbio.2013.02.033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
54 Takemoto K, Tateshima S, Rastogi S, Gonzalez N, Jahan R, Duckwiler G, Vinuela F. Disappearance of a small intracranial aneurysm as a result of vessel straightening and in-stent stenosis following use of an Enterprise vascular reconstruction device. BMJ Case Rep 2013;2013:bcr2012010583. [PMID: 23329725 DOI: 10.1136/bcr-2012-010583] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Iwasaki K, Kusachi S. Coronary pressure measurement based decision making for percutaneous coronary intervention. Curr Cardiol Rev 2009;5:323-33. [PMID: 21037849 DOI: 10.2174/157340309789317832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
56 Yakacki CM, Shandas R, Lanning C, Rech B, Eckstein A, Gall K. Unconstrained recovery characterization of shape-memory polymer networks for cardiovascular applications. Biomaterials 2007;28:2255-63. [PMID: 17296222 DOI: 10.1016/j.biomaterials.2007.01.030] [Cited by in Crossref: 431] [Cited by in F6Publishing: 321] [Article Influence: 28.7] [Reference Citation Analysis]
57 . Retraction. Urinary trypsin inhibitor reduced neointimal formation after stent implantation in minipig. Scand Cardiovasc J 2012;46:189. [PMID: 22390319 DOI: 10.3109/14017431.2012.672764] [Reference Citation Analysis]
58 Tombetti E, Di Chio MC, Sartorelli S, Papa M, Salerno A, Bottazzi B, Bozzolo EP, Greco M, Rovere-Querini P, Baldissera E, Del Maschio A, Mantovani A, De Cobelli F, Sabbadini MG, Manfredi AA. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis. Arthritis Res Ther 2014;16:479. [PMID: 25394473 DOI: 10.1186/s13075-014-0479-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
59 Park CB, Park HK. Identification of independent risk factors for restenosis following bare-metal stent implantation: Role of bare-metal stents in the era of drug-eluting stents. Exp Ther Med 2013;6:840-6. [PMID: 24137276 DOI: 10.3892/etm.2013.1212] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
60 Hayashi T, Kotani J, Ishibashi-Ueda H, Yasuda S. Thrombus-related focal in-stent restenosis after everolimus-eluting stent implantation. Heart Vessels 2014;29:273-7. [PMID: 23595778 DOI: 10.1007/s00380-013-0350-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
61 Tomasevic M, Rakocevic J, Dobric M, Aleksandric S, Labudovic M. Capturing Endothelial Cells by Coronary Stents - From Histology to Clinical Outcomes. Serbian Journal of Experimental and Clinical Research 2019;0:000010247820190018. [DOI: 10.2478/sjecr-2019-0018] [Reference Citation Analysis]
62 Shah SH, Hauser ER, Crosslin D, Wang L, Haynes C, Connelly J, Nelson S, Johnson J, Gadson S, Nelson CL. ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention. Atherosclerosis. 2008;201:148-154. [PMID: 18374923 DOI: 10.1016/j.atherosclerosis.2008.01.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
63 Elhendy A, Schinkel AF, van Domberg RT, Bax JJ, Valkema R, Poldermans D. Non-invasive diagnosis of in stent stenosis by stress 99m technetium tetrofosmin myocardial perfusion imaging. Int J Cardiovasc Imaging 2006;22:657-62. [PMID: 16628382 DOI: 10.1007/s10554-006-9087-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
64 Zhu X, Chen Y, Xiang L, You T, Jiao Y, Xu W, Chen J. The long-term prognostic significance of high-sensitive C-reactive protein to in-stent restenosis. Medicine (Baltimore) 2018;97:e10679. [PMID: 29979375 DOI: 10.1097/MD.0000000000010679] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
65 Alkhalil M, Conlon CP, Ashrafian H, Choudhury RP. Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection. World J Clin Cases 2017; 5(2): 40-45 [PMID: 28255546 DOI: 10.12998/wjcc.v5.i2.40] [Reference Citation Analysis]
66 Fang C, Zuo K, Fu Y, Li J, Wang H, Xu L, Yang X. Dysbiosis of Gut Microbiota and Metabolite Phenylacetylglutamine in Coronary Artery Disease Patients With Stent Stenosis. Front Cardiovasc Med 2022;9:832092. [DOI: 10.3389/fcvm.2022.832092] [Reference Citation Analysis]
67 Iofina E, Radke PW, Skurzewski P, Haager PK, Blindt R, Koch KC, Hanrath P, vom Dahl J, Hoffmann R. Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison. Heart 2005;91:1584-9. [PMID: 15797938 DOI: 10.1136/hrt.2004.047704] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
68 Zirdehi EM, Dumlu H, Eggeler G, Varnik F. On the Size Effect of Additives in Amorphous Shape Memory Polymers. Materials (Basel) 2021;14:E327. [PMID: 33435200 DOI: 10.3390/ma14020327] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Nakamura K, Keating JH, Edelman ER. Pathology of Endovascular Stents. Interv Cardiol Clin 2016;5:391-403. [PMID: 28582036 DOI: 10.1016/j.iccl.2016.02.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Panchenko MP, Siddiquee Z, Dombkowski DM, Alekseyev YO, Lenburg ME, Walker JD, Macgillivray TE, Preffer FI, Stone JR. Protein kinase CK1alphaLS promotes vascular cell proliferation and intimal hyperplasia. Am J Pathol 2010;177:1562-72. [PMID: 20696773 DOI: 10.2353/ajpath.2010.100327] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
71 Lekshmi KM, Che HL, Cho CS, Park IK. Drug- and Gene-eluting Stents for Preventing Coronary Restenosis. Chonnam Med J 2017;53:14-27. [PMID: 28184335 DOI: 10.4068/cmj.2017.53.1.14] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
72 Aizik G, Grad E, Golomb G. Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases. Drug Deliv Transl Res 2018;8:868-82. [PMID: 29058205 DOI: 10.1007/s13346-017-0431-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
73 Lyu N, Du Z, Qiu H, Gao P, Yao Q, Xiong K, Tu Q, Li X, Chen B, Wang M, Pan G, Huang N, Yang Z. Mimicking the Nitric Oxide-Releasing and Glycocalyx Functions of Endothelium on Vascular Stent Surfaces. Adv Sci (Weinh) 2020;7:2002330. [PMID: 33173746 DOI: 10.1002/advs.202002330] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
74 Onuta G, Groenewegen HC, Klatter FA, Walther Boer M, Goris M, van Goor H, Roks AJ, Rozing J, de Smet BJ, Hillebrands JL. Long-term type 1 diabetes enhances in-stent restenosis after aortic stenting in diabetes-prone BB rats. J Biomed Biotechnol 2011;2011:396734. [PMID: 21331346 DOI: 10.1155/2011/396734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
75 Kamath KR, Barry JJ, Miller KM. The Taxus drug-eluting stent: a new paradigm in controlled drug delivery. Adv Drug Deliv Rev 2006;58:412-36. [PMID: 16647782 DOI: 10.1016/j.addr.2006.01.023] [Cited by in Crossref: 135] [Cited by in F6Publishing: 110] [Article Influence: 8.4] [Reference Citation Analysis]